Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Reference12 articles.
1. Bayascas JR, Leslie NR, Parsons R, Fleming S, Alessi DR: Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/-) mice. Curr Biol. 2005, 15: 1839-1846. 10.1016/j.cub.2005.08.066.
2. Fyffe C, Falasca M: 3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer. Cancer Manag Res. 2013, 5: 271-280.
3. Eser S, Reiff N, Messer M, Seidler B, Gottschalk K, Dobler M, Hieber M, Arbeiter A, Klein S, Kong B, Michalski CV, Schlitter AM, Esposito I, Kind AJ, Rad L, Schnieke AE, Baccarini M, Alessi DR, Rad R, Schmid RM, Schneider G, Saur D: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell. 2013, 23: 406-420. 10.1016/j.ccr.2013.01.023.
4. Fujiwara S, Kawano Y, Yuki H, Okuno J, Nosaka K, Mitsuya H, Hata H: PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer. 2013, 108: 170-178. 10.1038/bjc.2012.527.
5. Pearn L, Fisher J, Burnett AK, Darley RL: The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood. 2007, 109: 4461-4469. 10.1182/blood-2006-09-047217.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献